Recombinant bacterial lipoproteins as vaccine candidates

References

• Wang W, Singh M. Selection of adjuvants for enhanced vaccine potency. World J Vaccine 2011;1:33-78
   Google Scholar
• Fikrig E, Barthold SW, Kantor FS, Flavell RA. Protection of mice against the Lyme disease agent by immunizing with recombinant OspA. Science 1990;250:553-6
   PubMed Web of Science ®Google Scholar
• Erdile LF, Brandt MA, Warakomski DJ, et al. Role of attached lipid in immunogenicity of Borrelia burgdorferi OspA. Infect Immun 1993;61:81-90
   PubMed Web of Science ®Google Scholar
• Johnson BJ, Sviat SL, Happ CM, et al. Incomplete protection of hamsters vaccinated with unlipidated OspA from Borrelia burgdorferi infection is associated with low levels of antibody to an epitope defined by mAb LA-2. Vaccine 1995;13:1086-94
   PubMed Web of Science ®Google Scholar
• Philipp MT, Lobet Y, Bohm RP, et al. The outer surface protein A (OspA) vaccine against Lyme disease: efficacy in the rhesus monkey. Vaccine 1997;15:1872-87
   PubMed Web of Science ®Google Scholar
• Infante-Duarte C, Kamradt T. Lipopeptides of Borrelia burgdorferi outer surface proteins induce Th1 phenotype development in alphabeta T-cell receptor transgenic mice. Infect Immun 1997;65:4094-9
   PubMed Web of Science ®Google Scholar
• Oftung F, Wiker HG, Deggerdal A, Mustafa AS. A novel mycobacterial antigen relevant to cellular immunity belongs to a family of secreted lipoproteins. Scand J Immunol 1997;46:445-51
   PubMed Web of Science ®Google Scholar
• Fletcher LD, Bernfield L, Barniak V, et al. Vaccine potential of the Neisseria meningitidis 2086 lipoprotein. Infect Immun 2004;72:2088-100
   PubMed Web of Science ®Google Scholar
• Jiang HQ, Hoiseth S, Harris SL, et al. Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease. Vaccine 2010;28:6086-93
   PubMed Web of Science ®Google Scholar
• Marchall HS, Richmond PC, Nissen MD, et al. Safety and immunogenicity of a meningococcal B bivalent rLP2086 vaccine in healthy toddlers aged 18-36 months: A phase 1 randomized-controlled clinical trial. Pediatr Infect Dis J 2012;31:1061-8
   PubMed Web of Science ®Google Scholar
• Brightbill HD, Libraty DH, Krutzik SR, et al. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 1999;285:732-6
   PubMed Web of Science ®Google Scholar
• Thoma-Uszynski S, Stenger S, Takeuchi O, et al. Induction of direct antimicrobial activity through mammalian toll-like receptors. Science 2001;291:1544-7
   PubMed Web of Science ®Google Scholar
• Hantke K, Braun V. Covalent binding of lipid to protein. Diglyceride and amide-linked fatty acid at the N-terminal end of the murein-lipoprotein of the Escherichia coli outer membrane. Eur J Biochem 1973;34:284-96
   PubMedGoogle Scholar
• Rezwan M, Grau T, Tschumi A, Sander P. Lipoprotein synthesis in mycobacteria. Microbiology 2007;153:652-8
   PubMed Web of Science ®Google Scholar
• De BK, Sampson JS, Ades EW, et al. Purification and characterization of Streptococcus pneumoniae palmitoylated pneumococcal surface adhesin A expressed in Escherichia coli. Vaccine 2000;18:1811-21
   PubMed Web of Science ®Google Scholar
• Legrain M, Speck D, Jacobs E. Production of lipidated meningococcal transferrin binding protein 2 in Escherichia coli. Protein Expr Purif 1995;6:570-8
   PubMed Web of Science ®Google Scholar
• Cullen PA, Lo M, Bulach DM, et al. Construction and evaluation of a plasmid vector for the expression of recombinant lipoproteins in Escherichia coli. Plasmid 2003;49:18-29
   PubMed Web of Science ®Google Scholar
• Kamalakkannan S, Murugan V, Jagannadham MV, et al. Bacterial lipid modification of proteins for novel protein engineering applications. Protein Eng Des Sel 2004;17:721-9
   PubMed Web of Science ®Google Scholar
• Hansson L, Noppa L, Nilsson AK, et al. Expression of truncated and full-length forms of the Lyme disease Borrelia outer surface protein A in Escherichia coli. Protein Expr Purif 1995;6:15-24
   PubMed Web of Science ®Google Scholar
• Madurawe RD, Chase TE, Tsao EI, Bentley WE. A recombinant lipoprotein antigen against Lyme disease expressed in E. coli: fermentor operating strategies for improved yield. Biotechnol Prog 2000;16:571-6
   PubMed Web of Science ®Google Scholar
• Shang ES, Summers TA, Haake DA. Molecular cloning and sequence analysis of the gene encoding LipL41, a surface-exposed lipoprotein of pathogenic Leptospira species. Infect Immun 1996;64:2322-30
   PubMed Web of Science ®Google Scholar
• A Database of Bacterial Lipoproteins. Available from: www.mrc-lmb.cam.ac.uk/genomes/dolop/analysis.shtml
   Google Scholar
• Dumon-Seignovert L, Cariot G, Vuillard L. The toxicity of recombinant proteins in Escherichia coli: a comparison of overexpression in BL21(DE3), C41(DE3), and C43(DE3). Protein Expr Purif 2004;37:203-6
   PubMed Web of Science ®Google Scholar
• Hsu CA, Lin WR, Li JC, et al. Immunoproteomic identification of the hypothetical protein NMB1468 as a novel lipoprotein ubiquitous in Neisseria meningitidis with vaccine potential. Proteomics 2008;8:2115-25
   PubMed Web of Science ®Google Scholar
• von Heijne G. The structure of signal peptides from bacterial lipoproteins. Protein Eng 1989;2:531-4
   PubMedGoogle Scholar
• Hayashi S, Wu HC. Lipoproteins in bacteria. J Bioenerg Biomembr 1990;22:451-71
   PubMed Web of Science ®Google Scholar
• Ignacio A, Miroux B, Karrasch S, et al. Characterization of new intracellular membranes in E. coli accompanying large scale over-production of the b subunit of F1F0 ATP synthase. FEBS Lett 2000;482:215-19
   PubMed Web of Science ®Google Scholar
• Chen HW, Liu SJ, Liu HH, et al. A novel technology for the production of a heterologous lipoprotein immunogen in high yield has implications for the field of vaccine design. Vaccine 2009;27:1400-9
   PubMed Web of Science ®Google Scholar
• Kwok Y, Sung WC, Lin AL, et al. Rapid isolation and characterization of bacterial lipopeptides using liquid chromatography and mass spectrometry analysis. Proteomics 2011;11:2620-7
   PubMed Web of Science ®Google Scholar
• Sung WC, Hsieh SY, Lin CL, et al. Biochemical characterizations of E. coli expressed protective antigen Ag473 of Neisseria meningitides group B. Vaccine 2010;28:8175-82
   PubMed Web of Science ®Google Scholar
• Reise Sousa C. Dendritic cells in a mature age. Nat Rev Immunol 2006;6:476-83
   PubMed Web of Science ®Google Scholar
• Lopez-Bravo M, Ardavin C. In vivo induction of immune responses to pathogens by conventional dendritic cells. Immunity 2008;29:343-51
   PubMed Web of Science ®Google Scholar
• Joffre O, Nolte MA, Spörri R, Reise Sousa C. Inflammatory signals in dendritic cell activation and the induction of adaptive immunity. Immunol Rev 2009;227:234-47
   PubMed Web of Science ®Google Scholar
• Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature 2007;449:819-26
   PubMed Web of Science ®Google Scholar
• Ishii KJ, Koyama S, Nakagawa A, et al. Host innate immune receptors and beyond: making sense of microbial infections. Cell Host Microbe 2008;3:352-63
   PubMed Web of Science ®Google Scholar
• Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010;140:805-20
   PubMed Web of Science ®Google Scholar
• Chu CL, Yu YL, Kung YC, et al. The immunomodulatory activity of meningococcal lipoprotein Ag473 depends on the conformation made up of the lipid and protein moieties. PLoS ONE 2012;7(7):e40873
   PubMed Web of Science ®Google Scholar
• Yang X, Izadi H, Coleman AS, et al. Borrelia burgdorferi lipoprotein BmpA activates pro-inflammatory responses in human synovial cells through a protein moiety. Microbes Infect 2008;10:1300-8
   PubMed Web of Science ®Google Scholar
• Pasquevich KA, García Samartino C, Coria LM, et al. The protein moiety of Brucella abortus outer membrane protein 16 is a new bacterial pathogen-associated molecular pattern that activates dendritic cells in vivo, induces a Th1 immune response, and is a promising self-adjuvanting vaccine against systemic and oral acquired brucellosis. J Immunol 2010;184:5200-12
   PubMed Web of Science ®Google Scholar
• Leng CH, Chen HW, Chang LS, et al. A recombinant lipoprotein containing an unsaturated fatty acid activates NF-kappaB through the TLR2 signaling pathway and induces a differential gene profile from a synthetic lipopeptide. Mol Immunol 2010;47:2015-21
   PubMed Web of Science ®Google Scholar
• Tseng CL, Leng CH. Influence of medium components on the expression of recombinant lipoproteins in Escherichia coli. Appl Microbiol Biotechnol 2012;93:1539-52
   PubMed Web of Science ®Google Scholar
• Chiang CY, Liu SJ, Tsai JP, et al. A novel single-dose dengue subunit vaccine induces memory immune responses. PLoS One 2011;6:e23319
   PubMed Web of Science ®Google Scholar
• Huang JH, Shen ZQ, Lien SP, et al. Biological and Immunological Characterizations of the Truncated Fragments of Receptor Binding Domain of C. difficile Toxin A. PLoS One 2015;10(8):e0135045
   Google Scholar
• Huang JH, Wu CW, Lien SP, et al. Recombinant lipoprotein-based vaccine candidates against C. difficile infections. J Biomedical Science 2015. [Epub ahead of print]
   Web of Science ®Google Scholar
• Huang CY, Chen HW, Shen KY, et al. Recombinant lipidated HPV E7 induces a Th-1-biased immune response and protective immunity against cervical cancer in a mouse model. PLoS One 2012;7:e40970
   PubMed Web of Science ®Google Scholar
• Song YC, Liu HH, Chen YH, et al. A purified recombinant lipopeptide as adjuvant for cancer immunotherapy. BioMed Research International 2014. Available from: www.hindawi.com/journals/bmri/2014/349783/
   Google Scholar